Clinical Trials Directory

Trials / Unknown

UnknownNCT03024814

Prophylactic Acetaminophen for Prevention Intraventricular Hemorrhage in Premature Infants

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
King Saud Medical City · Other Government
Sex
All
Age
1 Hour – 6 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether acetaminophen is effective in prevention or reducing the severity of IVH in premature infants.

Detailed description

It will be a double-blind randomized control trial, single center. The study will include neonates with a gestational age of less than or equal 32 weeks and a birth weight of less than or equal 1500 g, and will randomly assigned to two treatment groups (see below). Infants will be randomized to equal-sized groups using block randomization with blocks of four. Stratified randomization for gender and gestational age will be included in the randomized blocks. Gestational age will be divided into two categories: 23 weeks +0 day to 27 weeks +6 days, and from 28 weeks +0 day to 32 weeks +6 days. Gender (2) × gestational age (2) will give 6 strata, requiring 6 separate random number lists to achieve randomization.

Conditions

Interventions

TypeNameDescription
DRUGAcetaminophenThe first group will receive acetaminophen as the following 1. Loading dose: 20 mg/kg in the first 12-24 hours To be diluted in D5W up to 3-5 ml and to be infused over 15 minutes. 2. Maintenance dose: 7.5 mg/kg after 6 hrs from the loading dose and to be repeat every 6 hours for 3 days.
DRUGDextrose 5The second group will receive placebo (D5W) as the following 1. Loading dose: 3-5 ml in the first 12-24 hours To be infused over 15 minutes. 2. Maintenance dose: 3-5 ml after 6 hrs from the loading dose and to be repeat every 6 hours for 3 days.

Timeline

Start date
2016-10-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2017-01-19
Last updated
2017-01-19

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT03024814. Inclusion in this directory is not an endorsement.